Medically reviewed by Dr. Kevin Chua, Medical Director
Disclaimer: This article provides general medical information and is not a substitute for professional medical advice.
Semaglutide is the most-studied GLP-1 medication for weight loss, with extensive data in women. The STEP clinical trial programme included a majority of female participants, providing robust evidence for efficacy and safety in women. This guide covers women-specific aspects of semaglutide treatment.
Women responded comparably to men in clinical trials. In STEP 1, the average weight loss was 14.9% of body weight over 68 weeks1. Sub-analyses showed consistent efficacy across age groups, BMI categories, and hormonal status.
For women specifically, semaglutide offers additional benefits:
Women's hormonal health interacts with semaglutide in several important ways that require careful management.
Dosing is the same as for men — no gender-specific dose adjustment is needed.
| Phase | Dose | Duration |
|---|---|---|
| Initiation | 0.25 mg weekly | 4 weeks |
| Escalation | 0.5 mg → 1.0 mg → 1.7 mg → 2.4 mg | Each 4 weeks |
| Maintenance | 2.4 mg weekly (or highest tolerated) | Ongoing |
Some women are more sensitive to GI side effects and may benefit from slower dose escalation.
GLP-1 receptor agonist medications for weight management in Singapore typically cost SGD $200–500 per month depending on the specific medication and dosage. zoey™ offers structured weight management plans with ongoing doctor oversight and support.
Prices are approximate and may vary. Updated April 2026.
Semaglutide delays gastric emptying, which may theoretically reduce oral contraceptive absorption. Discuss with your doctor — you may need additional contraception or a switch to a non-oral method.
Yes. GLP-1 medications improve insulin sensitivity and promote weight loss — both of which address core PCOS mechanisms. Some studies show improvements in menstrual regularity and androgen levels with weight loss2.
Facial volume loss can occur with significant weight loss from any cause. Adequate protein intake (1.2–1.6 g/kg/day), slower weight loss, and hydration can minimise this. It's not specific to semaglutide.
Semaglutide is not recommended during breastfeeding due to limited safety data. Discuss timing of treatment with your doctor.
No significant interactions have been identified. Semaglutide can be used alongside HRT patches, gels, or tablets.
→ Return to pillar: Complete Guide to Medical Weight Loss for Women
This article is for informational purposes only and does not constitute medical advice. Always consult a licensed doctor before starting any treatment.
Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. PMID: 33567185 ↩
Davies MJ, Bergenstal R, Bode B, et al. Efficacy of liraglutide for weight loss among patients with type 2 diabetes. JAMA. 2015;314(7):687-699. PMID: 26132939 ↩

Articles featured on Zoey are for informational purposes only and should not be constituted as medical advice, diagnosis or treatment. If you have any medical questions or concerns, please talk to your healthcare provider. If you're looking for a healthcare provider, click here.